Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPS Challenge and Fluenz Immune Response
NCT02642237Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2015
- Primary completion
- Jan 2017
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Randomised, double-blind trial of live attenuated influenza vaccine in influenza, sponsored by Radboud University Medical Center. Primary endpoint: Interferon Gamma-induced Protein 10 at 35 days. Started Dec 2015; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02642237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02642237.